Related Experiment Video

Updated: Aug 19, 2026

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
06:29

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring

Published on: May 2, 2025

[Fontan right heart bypass as a corrective procedure for congenital heart disease with single-ventricle hemodynamics]

V P Podzolkov, M M Zelenikin, I A Iurlov

    Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
    |February 18, 2005
    PubMed

    Insights

    Surgical treatment for complex cyanotic congenital heart disease often requires hemodynamic correction. Extracardial bypass of the right heart using a valveless prosthesis is the optimal method, minimizing complications and improving outcomes through staged procedures and patient selection.

    Area of Science:

    • Cardiovascular Surgery
    • Pediatric Cardiology
    • Congenital Heart Disease

    Context:

    • Complex cyanotic congenital heart disease presents significant surgical challenges.
    • Restoring normal intracardiac hemodynamics is often impossible.
    • Hemodynamic correction reroutes venous blood, bypassing the right heart to the lungs.

    Purpose:

    • To analyze outcomes of various hemodynamic correction methods for complex cyanotic congenital heart disease.
    • To identify the optimal surgical approach for this patient population.
    • To explore strategies for improving early and long-term surgical outcomes.

    Summary:

    • Extracardial bypass of the right heart with a valveless tubular prosthesis is identified as the optimal surgical method.
    • This technique is associated with a low incidence of early and long-term complications.
    • Staged correction, including bidirectional cavopulmonary anastomosis, and meticulous patient selection enhance outcomes.

    Impact:

    • Provides a preferred surgical strategy for complex cyanotic congenital heart disease.
    • Offers a method with reduced complication rates for improved patient prognosis.
    • Highlights the importance of staged surgical interventions and preoperative optimization.

    More Related Videos

    Implantation of Total Artificial Heart in Congenital Heart Disease07:27

    Implantation of Total Artificial Heart in Congenital Heart Disease

    Published on: July 18, 2014

    Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)13:10

    Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)

    Published on: April 24, 2017

    Related Concept Videos

    Cardiac Catheterization II: Right Heart Catheterization01:21

    Cardiac Catheterization II: Right Heart Catheterization

    Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
    Mitral Regurgitation I: Introduction01:20

    Mitral Regurgitation I: Introduction

    Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
    Mitral Stenosis I: Introduction01:22

    Mitral Stenosis I: Introduction

    Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
    Chambers of the Heart01:16

    Chambers of the Heart

    The human heart is a complex organ made up of four chambers: the right and left atria and the right and left ventricles. These internal chambers are separated by partitions known as the interatrial and interventricular septa. The exterior of the heart features a groove known as the coronary sulcus that demarcates the atria from the ventricles, while the anterior and posterior interventricular sulci distinguish between the two ventricles.
    Deoxygenated blood from the body is received in the right...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.